Uncategorized
This Medford Clinic Is Developing a Coronavirus Vaccine, and You Wouldn’t Even Know It
Since July, the institute has been one of the staging grounds for a quest to find a vaccine for the novel coronavirus, which causes a disease that has killed more than 700 people in Oregon, more than 230,000 in the US, and 1.2 million worldwide. And inside, Gregg Lucksinger, the interim medical director of the institute, taps a business card against an oval wooden table in a brightly lit corner room. He leans back in an office chair and reminisces about the lessons learned in Liberia, where he worked in an Ebola treatment unit in 2015. He hopes those lessons will aide him and his colleagues now.
“In [Liberia], the epidemic overwhelmed health systems…. It was really fascinating to see that,” he says. “And that’s what we’re struggling with in the United States to prevent from happening. We’ve been really on the edge in a few places.”
Lucksinger’s work in clinical research began in Austin, Texas, during the HIV epidemic of the 1980s. He went on to help develop vaccines and/or therapeutics for HIV, hepatitis C, and Ebola.
Now, another complicated and highly contagious virus threatens humanity. Lucksinger and the institute in Oregon are working on two Phase 3 COVID-19 vaccine trials. The first, produced by biotech startup Moderna (which has been proven to reduce the risk of COVID-19 infection by 94.5 percent), has wrapped up its enrollment period and moved to data collection, a process by which research coordinators follow up with volunteers to see if they’ve developed symptoms of or contract the coronavirus as they go about their daily lives. This stage could take a year or two. The second trial is for a vaccine produced by Novavax. Under the White House’s Operation Warp Speed (OWS), a $10 billion initiative, COVID-19 vaccine and therapeutic trials have been accelerated, compressing what typically takes years into months. By running various processes in parallel and increasing the number of volunteers from a couple hundred to at least 30,000 for each trial, OWS hopes to have a vaccine by early 2021.
-
Crime & Safety4 days ago
Man, joined by his wife, gave famiIy members confIicting stories about where his chiId was after the 3-year-old had not been seen in months following the parent assauIting the boy to death, then tried to conceaI his death; charged
-
Crime & Safety4 days ago
Man had his eyebaII ripped out after asking random passerby ‘how is he doing,’ before the man approached the victim from behind, inserted his fingers into his socket, and pulled the eyebaII out; charges
-
Eugene6 days ago
Eugene Springfield Fire responds to commercial structure fire at Fred Meyer on Q St in Springfield
-
Eugene1 week ago
Eugene police arrest 18-year-old suspect in March 3 fatal shooting near 23rd and Willamette
-
Eugene1 week ago
Regional public safety agencies collaborate for mass casualty training exercise at Matthew Knight Arena
-
Eugene2 days ago
Crews respond to house fire in west Eugene, prevent spread to neighboring homes
-
Eugene6 days ago
Eugene Police Department conducts pedestrian safety operation at 17th and Hilyard, issues citations for violations
-
Eugene2 days ago
Man arrested after shots fired during altercation in Eugene apartment parking lot